Developer docs
API playgroundTry for free, no card

Search company profiles

Signal 1

Full company profile

uuid0000jgl

Namestring
Signal 1
Legal namestring
Signal 1 AI Inc.
Websiteurl
signal1.ai
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Signal 1 is a Toronto-based health AI company that builds an AI Management and Orchestration platform called AIMS, purpose-built for healthcare organizations. The platform enables health systems to govern, manage, and orchestrate agentic, generative, and predictive AI from a single interface and is composed of five integrated modules: AI Intake and Review (risk-classified onboarding with ServiceNow integration), AI Registry (centralized inventory of models and agents with standardized model cards), Post Deployment Monitoring (continuous performance and safety tracking with LLM-as-a-Judge evaluation), Agent Management (governance and orchestration of AI agents across platforms with auditable execution chains), and Portfolio Impact (ROI and usage dashboards for executive leaders). Underlying capabilities span predictive analytics, anomaly detection, generative AI evaluation, and process automation, with structured clinical data processing for patient-facing use cases.

In addition to the governance platform, Signal 1 markets clinical AI applications including CHARTWatch, a real-time patient deterioration risk predictor whose deployment at St. Michael's Hospital was associated with a 26% reduction in unexpected in-hospital deaths, and a Discharge Solution for hospital throughput. The company monetizes via enterprise SaaS subscriptions sold through a direct field sales motion to large North American hospital systems, with multi-year contracts and quote-based pricing. Customers and partners include Mount Sinai Health System, Inova Health, Trillium Health Partners, Unity Health Toronto, North York General, Nova Scotia Health, Vancouver Coastal Health, St. Michael's Hospital, the Coalition for Health AI, and Microsoft.

The company was founded in 2021 by Tomi Poutanen (former Chief AI Officer at TD Bank) and Mara Lederman (MIT-trained economist), with early backing from Dr. Geoffrey Hinton. It raised approximately $10M in seed funding in April 2022 led by Inovia Capital with participation from Radical Ventures and TD Bank Group, and operates with 11-50 employees. Signal 1 maintains SOC2 Type 2, HIPAA, and PIPEDA compliance and holds CHAI Assurance Service Provider Partner designation.

Short descriptiontext

Signal 1 builds AIMS, an enterprise SaaS platform that lets large health systems govern, monitor, and orchestrate their agentic, generative, and predictive AI portfolios across clinical, operational, and research domains.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare AI governance, AI management platform, clinical AI orchestration, AI lifecycle management, health system AI software
Industry3 codes
PRIMARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Computer Systems Design and Related Services54151
SIC code3 codes
  • Services-Computer Programming Services7371
  • Services-Computer Integrated Systems Design7373
  • Services-Health Services8000
Product category
Healthcare AI Governance Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AI Management Platform Subscription
TypeSubscription Recurring
Description

SaaS-based AI governance and management platform delivered as a subscription service to health systems. Platform provides centralized oversight, governance, performance monitoring, and ROI tracking for AI portfolios across clinical, operational, and research domains.

signal1.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise platform subscription - pricing not publicly disclosed
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed

signal1.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1AIMS (AI Management System)
Description

Signal 1's AI Management Platform providing centralized visibility, governance infrastructure, and technical capabilities to oversee AI across the full lifecycle. Enables health systems to govern, manage and orchestrate agentic, generative, and predictive AI on a single platform.

signal1.ai
Core offering1 text field

Signal 1 develops and sells AIMS (AI Management and Orchestration Platform), a purpose-built SaaS platform that enables health systems to govern, manage, and orchestrate agentic, generative, and predictive AI across the full lifecycle. The platform is complemented by clinical AI applications such as CHARTWatch (a real-time patient deterioration risk predictor) and a Discharge Solution for hospital discharge optimization. Customers are large hospital systems and health systems in North America.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 26% reduction in unexpected deaths in hospital settings
+2 more records
Product overview1 text field

Signal 1 offers a unified AI Management and Orchestration platform called AIMS (AI Management System) purpose-built for healthcare. The platform consists of six integrated modules: AI Intake and Review (for standardizing AI onboarding with risk classification), AI Registry (centralized inventory of all AI models), Post Deployment Monitoring (continuous performance and safety tracking), Agent Management (governance of AI agents across platforms), and Portfolio Impact (ROI tracking and investment decision support). The platform also includes flagship clinical applications such as CHARTWatch (real-time patient deterioration risk predictor) and the Discharge Solution (for hospital discharge optimization). Together, these products enable health systems to safely deploy, govern, and scale AI across clinical, operational, and research domains.

Product and service3 records
1AIMS (AI Management System)
CategoryAI Governance Platform
Description

Core AI management and orchestration platform that enables health systems to govern, manage, and orchestrate all agentic, generative, and predictive AI on a single platform that integrates into existing infrastructure. Includes modules for AI intake, registry, post-deployment monitoring, agent management, and portfolio impact tracking. Sold to large health systems as a multi-year subscription.

2CHARTWatch
CategoryClinical AI Application
Description

Real-time patient risk predictor and clinical AI early warning system for detecting patient deterioration. Deployed in hospitals to identify high-risk patients; clinical studies at St. Michael's Hospital showed a 26% reduction in unexpected deaths. Built for hospital clinical teams.

3Discharge Solution
CategoryClinical AI Application
Description

AI-powered tool for optimizing hospital discharge planning to improve patient throughput, hospital workflows, and capacity management. Deployed at Trillium Health Partners for discharge planning and ED prioritization.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-22
Description

Mount Sinai Health System, one of the nation's leading academic medical systems encompassing seven hospital campuses and three schools, partnered with Signal 1 to evaluate its AI Management Platform (AIMS) for centralizing oversight, governance, and performance monitoring of its expanding AI portfolio. The platform provides enterprise-wide visibility across clinical, operational, and research domains including imaging, generative AI, and agent-based systems.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-02
Description

Inova Health, the leading nonprofit healthcare provider in Northern Virginia and greater Washington DC region, selected Signal 1's AI Management Platform to centralize oversight, governance, and performance monitoring for its expanding AI portfolio. Inova is recognized as the first health system in the nation to commit to the Joint Commission's Responsible Use of Health Data criteria.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-23
Description

Signal 1 became CHAI's newest Assurance Service Provider Partner, helping set standards for responsible AI governance. This designation verifies that Signal 1's AI Management System supports rigorous AI governance and lifecycle management with robust post-deployment surveillance capabilities. CHAI membership exceeds 2,500 organizations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-28
Description

Trillium Health Partners (THP), one of Canada's largest community-based hospital systems, announced a multi-year strategic partnership with Signal 1 to accelerate safe AI adoption. THP uses Signal 1's Health AI Platform for discharge planning and ED prioritization, with collaboration to develop a best-in-class AI governance program.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-25
Description

Unity Health Toronto collaborated with Signal 1 to develop AI solutions for hospitals. The partnership supported the development and launch of CHARTWatch, a real-time patient risk predictor to improve hospital outcomes and workflows. The goal was to scale AI-driven healthcare innovations globally.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-25
Description

TD Bank Group partnered with Signal 1 to develop AI solutions for hospitals, combining financial services AI expertise with healthcare AI development. Signal 1's co-founder Tomi Poutanen previously served as Chief AI Officer at TD Bank, bringing enterprise AI scaling experience to the healthcare AI platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Signal 1

Healthcare AI Governance Softwaresignal1.ai

Signal 1 builds AIMS, an enterprise SaaS platform that lets large health systems govern, monitor, and orchestrate their agentic, generative, and predictive AI portfolios across clinical, operational, and research domains.

What Signal 1 does

Signal 1 is a Toronto-based health AI company that builds an AI Management and Orchestration platform called AIMS, purpose-built for healthcare organizations. The platform enables health systems to govern, manage, and orchestrate agentic, generative, and predictive AI from a single interface and is composed of five integrated modules: AI Intake and Review (risk-classified onboarding with ServiceNow integration), AI Registry (centralized inventory of models and agents with standardized model cards), Post Deployment Monitoring (continuous performance and safety tracking with LLM-as-a-Judge evaluation), Agent Management (governance and orchestration of AI agents across platforms with auditable execution chains), and Portfolio Impact (ROI and usage dashboards for executive leaders). Underlying capabilities span predictive analytics, anomaly detection, generative AI evaluation, and process automation, with structured clinical data processing for patient-facing use cases.

In addition to the governance platform, Signal 1 markets clinical AI applications including CHARTWatch, a real-time patient deterioration risk predictor whose deployment at St. Michael's Hospital was associated with a 26% reduction in unexpected in-hospital deaths, and a Discharge Solution for hospital throughput. The company monetizes via enterprise SaaS subscriptions sold through a direct field sales motion to large North American hospital systems, with multi-year contracts and quote-based pricing. Customers and partners include Mount Sinai Health System, Inova Health, Trillium Health Partners, Unity Health Toronto, North York General, Nova Scotia Health, Vancouver Coastal Health, St. Michael's Hospital, the Coalition for Health AI, and Microsoft.

The company was founded in 2021 by Tomi Poutanen (former Chief AI Officer at TD Bank) and Mara Lederman (MIT-trained economist), with early backing from Dr. Geoffrey Hinton. It raised approximately $10M in seed funding in April 2022 led by Inovia Capital with participation from Radical Ventures and TD Bank Group, and operates with 11-50 employees. Signal 1 maintains SOC2 Type 2, HIPAA, and PIPEDA compliance and holds CHAI Assurance Service Provider Partner designation.

Signal 1 firmographics

Firmographics
Name
Signal 1
Legal name
Signal 1 AI Inc.
Website
https://signal1.ai
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Signal 1 builds AIMS, an enterprise SaaS platform that lets large health systems govern, monitor, and orchestrate their agentic, generative, and predictive AI portfolios across clinical, operational, and research domains.
Ownership category
akta.pro rank

Signal 1 industry classification

Industry
Product category
Healthcare AI Governance Software
NAICS
Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
SIC
Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373), Services-Health Services (8000)
akta.pro industry
PRIMARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Healthcare AI governance
  • AI management platform
  • Clinical AI orchestration
  • AI lifecycle management
  • Health system AI software

Where Signal 1 is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Signal 1 business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. AI Management Platform Subscription: SaaS-based AI governance and management platform delivered as a subscription service to health systems. Platform provides centralized oversight, governance, performance monitoring, and ROI tracking for AI portfolios across clinical, operational, and research domains.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise platform subscription - pricing not publicly disclosed

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Signal 1 product offering

Product offering

Core offering

Signal 1 develops and sells AIMS (AI Management and Orchestration Platform), a purpose-built SaaS platform that enables health systems to govern, manage, and orchestrate agentic, generative, and predictive AI across the full lifecycle. The platform is complemented by clinical AI applications such as CHARTWatch (a real-time patient deterioration risk predictor) and a Discharge Solution for hospital discharge optimization. Customers are large hospital systems and health systems in North America.

Product overview

Signal 1 offers a unified AI Management and Orchestration platform called AIMS (AI Management System) purpose-built for healthcare. The platform consists of six integrated modules: AI Intake and Review (for standardizing AI onboarding with risk classification), AI Registry (centralized inventory of all AI models), Post Deployment Monitoring (continuous performance and safety tracking), Agent Management (governance of AI agents across platforms), and Portfolio Impact (ROI tracking and investment decision support). The platform also includes flagship clinical applications such as CHARTWatch (real-time patient deterioration risk predictor) and the Discharge Solution (for hospital discharge optimization). Together, these products enable health systems to safely deploy, govern, and scale AI across clinical, operational, and research domains.

Differentiator

Problem solved

Functional benefit

Brands

  • AIMS (AI Management System): Signal 1's AI Management Platform providing centralized visibility, governance infrastructure, and technical capabilities to oversee AI across the full lifecycle. Enables health systems to govern, manage and orchestrate agentic, generative, and predictive AI on a single platform.

Products and services

  • AIMS (AI Management System) Core AI management and orchestration platform that enables health systems to govern, manage, and orchestrate all agentic, generative, and predictive AI on a single platform that integrates into existing infrastructure. Includes modules for AI intake, registry, post-deployment monitoring, agent management, and portfolio impact tracking. Sold to large health systems as a multi-year subscription.
  • CHARTWatch Real-time patient risk predictor and clinical AI early warning system for detecting patient deterioration. Deployed in hospitals to identify high-risk patients; clinical studies at St. Michael's Hospital showed a 26% reduction in unexpected deaths. Built for hospital clinical teams.
  • Discharge Solution AI-powered tool for optimizing hospital discharge planning to improve patient throughput, hospital workflows, and capacity management. Deployed at Trillium Health Partners for discharge planning and ED prioritization.

Quantifiable outcome

  • 26% reduction in unexpected deaths in hospital settings
  • +2 more outcomes

Companies that use Signal 1

Customer profile

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Signal 1 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature8 records

Signal 1 partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Mount Sinai Health SystemcoreStrategic or Co-development Partner · 22 June 2026Mount Sinai Health System, one of the nation's leading academic medical systems encompassing seven hospital campuses and three schools, partnered with Signal 1 to evaluate its AI Management Platform (AIMS) for centralizing oversight, governance, and performance monitoring of its expanding AI portfolio. The platform provides enterprise-wide visibility across clinical, operational, and research domains including imaging, generative AI, and agent-based systems.
  • Inova HealthcoreStrategic or Co-development Partner · 2 December 2025Inova Health, the leading nonprofit healthcare provider in Northern Virginia and greater Washington DC region, selected Signal 1's AI Management Platform to centralize oversight, governance, and performance monitoring for its expanding AI portfolio. Inova is recognized as the first health system in the nation to commit to the Joint Commission's Responsible Use of Health Data criteria.
  • Coalition for Health AI (CHAI)coreStrategic or Co-development Partner · 23 June 2025Signal 1 became CHAI's newest Assurance Service Provider Partner, helping set standards for responsible AI governance. This designation verifies that Signal 1's AI Management System supports rigorous AI governance and lifecycle management with robust post-deployment surveillance capabilities. CHAI membership exceeds 2,500 organizations.
  • Trillium Health PartnerscoreStrategic or Co-development Partner · 28 October 2024Trillium Health Partners (THP), one of Canada's largest community-based hospital systems, announced a multi-year strategic partnership with Signal 1 to accelerate safe AI adoption. THP uses Signal 1's Health AI Platform for discharge planning and ED prioritization, with collaboration to develop a best-in-class AI governance program.
  • Unity Health TorontocoreStrategic or Co-development Partner · 25 April 2022Unity Health Toronto collaborated with Signal 1 to develop AI solutions for hospitals. The partnership supported the development and launch of CHARTWatch, a real-time patient risk predictor to improve hospital outcomes and workflows. The goal was to scale AI-driven healthcare innovations globally.
  • TD Bank GroupcoreStrategic or Co-development Partner · 25 April 2022TD Bank Group partnered with Signal 1 to develop AI solutions for hospitals, combining financial services AI expertise with healthcare AI development. Signal 1's co-founder Tomi Poutanen previously served as Chief AI Officer at TD Bank, bringing enterprise AI scaling experience to the healthcare AI platform.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Signal 1 competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Signal 1 social profiles

Digital presence

Signal 1 compliance and trust

Trust signal

Compliance3 records

Signal 1 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Signal 1 leadership team

Management profile

Number of profiles

Profiles4 records

Signal 1 funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Signal 1 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signal 1

What does Signal 1 do?

Signal 1 develops and sells AIMS (AI Management and Orchestration Platform), a purpose-built SaaS platform that enables health systems to govern, manage, and orchestrate agentic, generative, and predictive AI across the full lifecycle. The platform is complemented by clinical AI applications such as CHARTWatch (a real-time patient deterioration risk predictor) and a Discharge Solution for hospital discharge optimization. Customers are large hospital systems and health systems in North America.

Is Signal 1 a public or private company?

Signal 1 is a private company. It is classified as venture growth investor backed and is currently operating.

When was Signal 1 founded?

Signal 1 was founded in 2021. It employs 11 to 50 people.

Where is Signal 1 based?

Signal 1 is headquartered in Toronto, Canada, in the North America region.

How does Signal 1 make money?

One revenue line is on record: AI Management Platform Subscription.

Does Signal 1 have an API?

No public API is recorded for Signal 1.

What industry is Signal 1 in?

Signal 1's product category is Healthcare AI Governance Software. Its primary akta.pro industry code is HDAEANAF, AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety), with a secondary code of HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management). Its NAICS code is 541511 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ThelogicSignal 1 signs deal with Newfoundland health authority to bolster Canadian businessSignal 1, a Toronto-based AI health-care firm, signed a deal with Newfoundland and Labrador's medical authority to use its AI management system (AIMS). The system evaluates and monitors AI applications, with clients including Nova Scotia Health and North York General Hospital. The firm plans to expand to other Canadian provincial health systems.BeckershospitalreviewNewYork-Presbyterian to govern all its AI tools through 1 systemNewYork-Presbyterian has adopted Signal 1's AI Management System (AIMS) to govern and monitor all artificial intelligence tools deployed across its New York City-based health system. The platform will oversee AI technologies ranging from cancer and structural heart disease detection to clinical documentation applications. This move reflects a broader industry shift as health systems increasingly manage AI as a unified portfolio rather than evaluating each tool individually.FierceHealthcareWeekly Rundown: Innovaccer, AWS ink strategic collaboration; Mount Sinai adopts Signal 1 for AI managementInnovaccer and Amazon Web Services signed a multi-year strategic collaboration to help health systems deploy agentic AI solutions at scale using AWS infrastructure. Concurrently, Mount Sinai Health System partnered with Signal 1 to centralize oversight of its AI portfolio, while Houston Methodist deployed HealthLeap's AI platform for clinical nutrition screening.BetaKitSignal 1’s AI platform adopted by New York’s Mount Sinai Health SystemToronto-based Signal 1 has partnered with New York City-based Mount Sinai Health System to deploy its AI management platform for monitoring and governance of the health system's AI tools. The platform will help track, evaluate, and optimize AI deployment across Mount Sinai's seven hospitals and three schools. The partnership, announced Monday, positions Signal 1 as a key AI governance partner for major US healthcare networks.Business Wire BlogMount Sinai Health System Partners with Signal 1 to Strengthen AI Governance and Accelerate Value RealizationMount Sinai Health System has partnered with Signal 1 to evaluate Signal 1's AI Management Platform (AIMS) for centralizing oversight, governance, and performance monitoring of its expanding portfolio of artificial intelligence solutions. The platform will provide enterprise-wide visibility into all AI tools, streamline intake and approval workflows, enable automated monitoring and reporting, and support ROI tracking across clinical, operational, and research applications. The partnership aims to help Mount Sinai scale AI oversight without slowing innovation as the health system expands into generative AI and agent-based systems.FinancialContent Business PageMount Sinai Health System Partners with Signal 1 to Strengthen AI Governance and Accelerate Value RealizationMount Sinai Health System has partnered with Signal 1 to adopt Signal 1's AI Management Platform (AIMS) for centralized oversight, governance, and performance monitoring of its expanding portfolio of artificial intelligence solutions. The platform will provide enterprise-wide visibility into AI tools across clinical, operational, and research domains, including imaging, generative AI, and agent-based systems. The partnership aims to deliver measurable improvements in patient care, provider experience, and system performance by enabling scalable oversight without building infrastructure in-house.MorningstarMount Sinai Health System Partners with Signal 1 to Strengthen AI Governance and Accelerate Value RealizationMount Sinai Health System will evaluate Signal 1's AI Management Platform to centralize oversight and performance monitoring for its expanding AI portfolio. The partnership aims to provide enterprise-wide visibility, standardized evaluation, and operational efficiency without building infrastructure. Signal 1's CEO highlighted the platform's design for generative and agentic AI governance.The Globe and MailThese companies are leveraging AI to improve Canada’s stressed health care systemThree Canadian companies are using AI to address Canada's strained health care system: Signal 1 predicts patient deterioration and discharge readiness, Scrubs Co-Pilot automates physician note-taking, and Clarius Mobile Health uses AI to guide handheld ultrasound imaging. Signal 1's CHARTwatch predicts patient risk, while Scrubs Co-Pilot saves doctors two to three hours daily, and Clarius's AI-assisted ultrasound is used in over 100 rural B.C. locations.MarkTechPostThis Canadian Health-AI startup is Bringing Machine Learning-Driven Insights Into Existing Workflows To Improve Patient OutcomesSignal 1, a Canadian health-AI startup, is integrating machine learning into hospital workflows to improve patient outcomes. Its CHARTWatch tool predicts patient risk and has been used by St. Michael's Hospital since October 2020, with clinicians 15% better at predicting deterioration. The company raised $10 million in seed funding led by Inovia Capital.NewswireHealth AI startup Signal 1 announces collaboration with Unity Health Toronto and TD Bank Group to bring clinically-validated AI applications to hospitals worldwideHealth AI startup Signal 1 announced strategic collaborations with Unity Health Toronto and TD Bank Group to commercialize clinically-validated AI applications in hospitals. The venture launched with $10 million in seed funding led by Inovia Capital, which includes a $4 million investment from TD Bank. The partnership aims to scale AI solutions like the CHARTWatch patient risk predictor to address healthcare system challenges such as staff shortages and patient backlogs.